Does IMATINIB Cause Activated partial thromboplastin time prolonged? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Activated partial thromboplastin time prolonged have been filed in association with IMATINIB (Imatinib). This represents 0.1% of all adverse event reports for IMATINIB.
21
Reports of Activated partial thromboplastin time prolonged with IMATINIB
0.1%
of all IMATINIB reports
2
Deaths
12
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From IMATINIB?
Of the 21 reports, 2 (9.5%) resulted in death, 12 (57.1%) required hospitalization.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which IMATINIB Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL